Markus Loeffler MD

International Clinical Leader Oncology

Markus Loeffler MD

Markus Loeffler was formerly Head of Global Medical Affairs at the international headquarters of AAA, a mid-size pharmaceutical company, where he was responsible for the analysis and publication of the Phase III data from the registration study for Lutathera, a drug for the treatment of neuroendocrine tumours. He has an MD from the University of Innsbruck in Austria, together with an MBA from INSEAD and over 20 years of academic and industry leadership experience, working for small start-up as well as top tier pharmaceutical companies, such as Boehringer Ingelheim and Roche.